YARDLEY, PA--(Marketwire - March 19, 2009) - Almac Clinical Technologies announced today that it will be showcasing its enhanced ePRO capabilities at the DIA’s 21st Annual EuroMeeting located in Berlin, Germany, 23-25 March. Almac collects PRO (patient reported outcomes) data via the phone or web in clinical trials through its industry-leading integrated Interactive Voice and Web Response System.
The technology showcased at Almac’s booth (#1512) will include various aspects of the firm’s ePRO offering. The demonstration will include examples of patients’ access to the system via the phone and the Internet, showcasing the system’s ability to work in either Web or phone mode interchangeably throughout the life of a study. Web demonstrations will exemplify how Almac’s system recreates paper-based questionnaires on the Web interface, making it more familiar to patients that are using the Internet to log subjective data for the first time. Other capabilities being demonstrated include a ‘clickable’ body diagram that is intuitive and very useful for patients, as well as branching capabilities to support complex questionnaire designs.
Almac’s VP of Product Development Fritz Haas explains, “Almac’s state-of-the art integrated IVR/IWR technology platform is only part of our ePRO solution. Our clinical experience providing patient management and randomization services, biostatistical support, and clinical data through our IVR/IWR and EDC technologies enhances Almac’s e-PRO offerings. Our experienced project managers, biostatisticians and best-in-class alliance partners help our clients from study design to trial completion, including instrument selection, validation, linguistics issues, psychometric evaluations, technology set-up, and data integration services.”
Come visit Almac at Booth 1512 to learn more about its ePRO capabilities and suite of clinical technologies.
About Almac Clinical Technologies
Almac Clinical Technologies is a division of the Almac Group that specializes in interactive technology and service solutions to increase the quality and efficiency of the clinical trial process. Our solutions include Interactive Voice and Web Response Systems (IXRS™) for patient randomization, tracking and clinical supply management; iTrial EDC for electronic case report form data collection; electronic patient reported outcomes data collection; and Web drug reconciliation. Almac’s technologies have been deployed in over 1300 clinical trials, incorporating over 1.5 million patients in over 80 countries and more than 60 languages.
About Almac Group:
The Almac Group comprises five closely integrated divisions offering a broad range of services from R&D, translational genomic services, API manufacture, formulation development, clinical trial supply and technology (IVRS/Web/EDC), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors.
The company employs over 2,400 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California. Construction of the company’s new $112m North American Headquarters started in July 08 and is expected to be completed 2010.
For more information about the Almac Group, please visit www.almacgroup.com or e-mail info@almacgroup.com.
Contact:
Meghan Adams
T: (001) 267-685-4284
E: Email Contact
W: www.almacgroup.com
